<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK2591" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK2591/" /><meta name="ncbi_pagename" content="Arts Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Arts Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Arts Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/03/22" /><meta name="citation_author" content="Arjan PM de Brouwer" /><meta name="citation_author" content="John Christodoulou" /><meta name="citation_pmid" content="20301738" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK2591/" /><meta name="citation_keywords" content="Ribose-phosphate pyrophosphokinase 1" /><meta name="citation_keywords" content="PRPS1" /><meta name="citation_keywords" content="Arts Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Arts Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Arjan PM de Brouwer" /><meta name="DC.Contributor" content="John Christodoulou" /><meta name="DC.Date" content="2018/03/22" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK2591/" /><meta name="description" content="Arts syndrome, which is part of the spectrum of PRPS1-related disorders, is characterized by profound congenital sensorineural hearing impairment, early-onset hypotonia, delayed motor development, mild to moderate intellectual disability, ataxia, and increased risk of infection, all of which – with the exception of optic atrophy – present before age two years. Signs of peripheral neuropathy develop during early childhood. Twelve of 15 boys from the two Dutch families reported with Arts syndrome died before age six years of complications of infection. Carrier females can show late-onset (age &gt;20 years) hearing impairment and other findings." /><meta name="og:title" content="Arts Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Arts syndrome, which is part of the spectrum of PRPS1-related disorders, is characterized by profound congenital sensorineural hearing impairment, early-onset hypotonia, delayed motor development, mild to moderate intellectual disability, ataxia, and increased risk of infection, all of which – with the exception of optic atrophy – present before age two years. Signs of peripheral neuropathy develop during early childhood. Twelve of 15 boys from the two Dutch families reported with Arts syndrome died before age six years of complications of infection. Carrier females can show late-onset (age &gt;20 years) hearing impairment and other findings." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK2591/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/arts/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK2591/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE884D11DFC848F1000000000502023F.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK2591_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK2591_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/arterial-t/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mld/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK2591_"><span class="title" itemprop="name">Arts Syndrome</span></h1><p class="contrib-group"><span itemprop="author">Arjan PM de Brouwer</span>, PhD and <span itemprop="author">John Christodoulou</span>, MBBS, PhD.</p><a data-jig="ncbitoggler" href="#__NBK2591_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK2591_ai__"><div class="contrib half_rhythm"><span itemprop="author">Arjan PM de Brouwer</span>, PhD<div class="affiliation small">Assistant Professor, Department of Human Genetics<br />Radboud University Nijmegen Medical Center<br />Nijmegen, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmuduobdar@rewuorbed.najra" class="oemail">ln.cmuduobdar@rewuorbed.najra</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">John Christodoulou</span>, MBBS, PhD<div class="affiliation small">Director, Genetics Research Theme<br />Murdoch Children&#x02019;s Research Institute<br />Chair of Genomic Medicine, Department of Paediatrics<br />University of Melbourne<br />Melbourne, Australia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ua.ude.ircm@uoluodotsirhc.nhoj" class="oemail">ua.ude.ircm@uoluodotsirhc.nhoj</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">October 21, 2008</span>; Last Update: <span itemprop="dateModified">March 22, 2018</span>.</p><p><em>Estimated reading time: 15 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="arts.Summary" itemprop="description"><h2 id="_arts_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Arts syndrome, which is part of the spectrum of <i>PRPS1</i>-related disorders, is characterized by profound <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> sensorineural hearing impairment, early-onset hypotonia, delayed motor development, mild to moderate intellectual disability, ataxia, and increased risk of infection, all of which &#x02013; with the exception of optic atrophy &#x02013; present before age two years. Signs of peripheral neuropathy develop during early childhood. Twelve of 15 boys from the two Dutch families reported with Arts syndrome died before age six years of complications of infection. Carrier females can show late-onset (age &#x0003e;20 years) hearing impairment and other findings.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of Arts syndrome can be established in a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with absent ribose-phosphate pyrophosphokinase 1 (PRS-I) enzyme activity in erythrocytes, or significantly lower PRS-1 enzyme activity in fibroblasts than in controls, or identification of a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PRPS1</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. The diagnosis of Arts syndrome can be established in a female proband with suggestive clinical features and identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variant in <i>PRPS1</i> by molecular genetic testing.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Educational program tailored to individual needs. Sensorineural hearing loss has been treated with cochlear implantation with good results. Ataxia and visual impairment from optic atrophy are treated in a routine manner.</p><p><i>Prevention of secondary complications:</i> Routine immunizations against common childhood infections and annual influenza immunization.</p><p><i>Surveillance:</i> Regular neuropsychological, audiologic, and ophthalmologic examinations.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Arts syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. If the mother is a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, the chance of transmitting the <i>PRPS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in each pregnancy is 50%. Males who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the pathogenic variant will be carriers and may or may not be mildly affected. Males with Arts syndrome have not reproduced. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variant in the family is known.</p></div></div><div id="arts.Diagnosis"><h2 id="_arts_Diagnosis_">Diagnosis</h2><p>Formal diagnostic criteria for Arts syndrome have not been established.</p><div id="arts.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Arts syndrome, part of the spectrum of <i>PRPS1</i>-related disorders, <b>should be suspected in</b>
<b>a male</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b> with the following clinical and laboratory features.</p><p><b>Clinical features</b></p><ul><li class="half_rhythm"><div>Intellectual disability</div></li><li class="half_rhythm"><div>Profound <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> sensorineural hearing impairment</div></li><li class="half_rhythm"><div>Early-onset hypotonia</div></li><li class="half_rhythm"><div>Delayed motor development</div></li><li class="half_rhythm"><div>Ataxia</div></li><li class="half_rhythm"><div>Optic atrophy</div></li><li class="half_rhythm"><div>Liability to infections, especially of the upper respiratory tract</div></li></ul><p><b>Laboratory features</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Serum uric acid</b> concentration lower than average (0.13-0.16 mmol/L), although still within the normal range (i.e., 0.12-0.35 mmol/L) [<a class="bk_pop" href="#arts.REF.de_brouwer.2007.507">de Brouwer et al 2007</a>]</div><div class="half_rhythm">Note: (1) Serum uric acid concentration is not zero because PRS-II, which has the same enzyme activity as PRS-I, is active in tissues such as liver, which consequently will result in purine nucleotide synthesis and uric acid production. (2) However, a low/normal serum uric acid concentration may be helpful in ruling out a diagnosis of <a href="/books/n/gene/prs/">PRS superactivity</a>, in which serum uric acid concentration is usually high.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Purine</b>
<b>analysis in urine</b></div><ul><li class="half_rhythm"><div>Absent/low hypoxanthine on analysis of purines in the urine</div></li><li class="half_rhythm"><div>When individuals with Arts syndrome are on a low-purine diet, the uric acid to creatinine ratio in urine may also tend to be at the lower end of normal, but not zero.</div></li><li class="half_rhythm"><div>Concentrations of other purines in urine within the normal range</div></li></ul></li></ul><p>Arts syndrome <b>should be suspected in</b>
<b>a female</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b> with late-onset (age &#x0003e;20 years) sensorineural hearing impairment.</p></div><div id="arts.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p><b>Male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b>. The diagnosis of Arts syndrome <b>is established</b> in a male proband with ANY of the following:</p><ul><li class="half_rhythm"><div>Absent ribose-phosphate pyrophosphokinase 1 (PRS-I) enzyme activity in erythrocytes (because PRS-I is the only isoform present)</div></li><li class="half_rhythm"><div>Significantly lower ribose-phosphate pyrophosphokinase 1 (PRS-I) enzyme activity in fibroblasts than in controls [<a class="bk_pop" href="#arts.REF.de_brouwer.2007.507">de Brouwer et al 2007</a>]</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PRPS1</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK2591/table/arts.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figartsTmoleculargenetictestingusedin" rid-ob="figobartsTmoleculargenetictestingusedin">Table 1</a>)</div></li></ul><p><b>Female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b>. The diagnosis of Arts syndrome is usually established in a female proband with late-onset (age &#x0003e;20 years) sensorineural hearing impairment and identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PRPS1</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK2591/table/arts.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figartsTmoleculargenetictestingusedin" rid-ob="figobartsTmoleculargenetictestingusedin">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of Arts syndrome is broad, individuals with the distinctive findings described in <a href="#arts.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#arts.Option_1">Option 1</a>), whereas those in whom the diagnosis of Arts syndrome has not been considered are more likely to be diagnosed using genomic testing (see <a href="#arts.Option_2">Option 2</a>).</p><div id="arts.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of Arts syndrome <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>PRPS1</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>PRPS1</i> and other genes of interest (see <a href="#arts.Differential_Diagnosis">Differential Diagnosis</a>) may be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="arts.Option_2"><h4>Option 2</h4><p>When the diagnosis of Arts syndrome is not considered because an individual has atypical phenotypic features, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is the most commonly used genomic testing method; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="arts.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Arts Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK2591/table/arts.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__arts.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_arts.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_arts.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_arts.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_arts.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>PRPS1</i></td><td headers="hd_h_arts.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3,&#x000a0;4</sup></td><td headers="hd_h_arts.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4 families&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_arts.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_arts.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="arts.TF.1.1"><p class="no_margin">See <a href="/books/NBK2591/#arts.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="arts.TF.1.2"><p class="no_margin">See <a href="#arts.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="arts.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="arts.TF.1.4"><p class="no_margin">Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation requires additional testing by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div></dd><dt>5. </dt><dd><div id="arts.TF.1.5"><p class="no_margin">Four families reported to date [<a class="bk_pop" href="#arts.REF.de_brouwer.2007.507">de Brouwer et al 2007</a>, <a class="bk_pop" href="#arts.REF.synofzik.2014.24">Synofzik et al 2014</a>, <a class="bk_pop" href="#arts.REF.maruyama.2016.954">Maruyama et al 2016</a>]</p></div></dd><dt>6. </dt><dd><div id="arts.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="arts.TF.1.7"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd></dl></div></div></div></div></div></div><div id="arts.Clinical_Characteristics"><h2 id="_arts_Clinical_Characteristics_">Clinical Characteristics</h2><div id="arts.Clinical_Description"><h3>Clinical Description</h3><p>Arts syndrome is characterized by intellectual disability, early-onset hypotonia, ataxia, delayed motor development, profound <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> sensorineural hearing impairment, and progressive optic atrophy [<a class="bk_pop" href="#arts.REF.arts.1993.535">Arts et al 1993</a>, <a class="bk_pop" href="#arts.REF.de_brouwer.2007.507">de Brouwer et al 2007</a>].</p><p>At birth these symptoms can be present in various combinations. All symptoms except for the visual impairment become apparent in the first two years of life. Visual impairment usually becomes obvious after age two years.</p><p>Delayed motor nerve conduction velocities and an electromyography suggestive of denervation develop during early childhood and are consistent with clinical findings that suggest peripheral neuropathy.</p><p>Affected males usually have mild to moderate intellectual disability; however, cognitive abilities can be difficult to assess in the presence of combined visual and hearing impairment.</p><p>Liability to infections, especially upper-respiratory tract infections, resulted in death before age six years in 12 of 15 boys from the two Dutch families reported with Arts syndrome. During infection, the slowly progressive muscle weakness is punctuated by acute deterioration in muscle strength, which may result in respiratory failure requiring mechanical ventilation.</p><p><b>Heterozygous females</b> can show <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> and/or milder manifestations, most notably late-onset (age &#x0003e;20 years) hearing impairment. Ataxia (in 2 females), hypotonia (1 female), and hyperreflexia (1 female) have been reported as well [<a class="bk_pop" href="#arts.REF.arts.1993.535">Arts et al 1993</a>].</p><p><b>MRI</b> shows no recognizable abnormalities (e.g., reduction of white matter in the brain, which would indicate demyelination) [<a class="bk_pop" href="#arts.REF.de_brouwer.2007.507">de Brouwer et al 2007</a>].</p><p><b>Sural nerve biopsy</b> in a boy age five years with Arts syndrome from the original Dutch family showed a loss of myelinated fibers, but no signs of demyelination or axonal degeneration [<a class="bk_pop" href="#arts.REF.arts.1993.535">Arts et al 1993</a>]. Sural nerve biopsy of a boy age two years from the Australian family, who had absent lower-limb deep tendon reflexes and nerve conduction studies indicative of peripheral neuropathy, showed mild paranodal demyelination indicative of peripheral neuropathy [<a class="bk_pop" href="#arts.REF.de_brouwer.2007.507">de Brouwer et al 2007</a>].</p><p><b>Autopsy</b> of one individual who died at age five and a half years revealed complete absence of myelinated axons in the posterior columns of the spinal cord, although their number and appearance were normal in the other tracts [<a class="bk_pop" href="#arts.REF.arts.1993.535">Arts et al 1993</a>]. A number of dorsal root nerves showed the same abnormalities as posterior columns. No abnormalities were seen in the brain stem or in the gray and white matter of the cerebral and cerebellar hemispheres.</p></div><div id="arts.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Computer-assisted molecular modeling showed that pathogenic variants causing Arts syndrome and <a href="/books/n/gene/cmtx5/">CMTX5</a> disturb the ATP binding site of PRS-I.</p><p>Pathogenic variants that result in <a href="/books/n/gene/prs/">PRS superactivity</a> disturb either one or both allosteric sites that are involved in the inhibition of PRS-I enzyme activity.</p><p>Pathogenic variants that lead to <a href="/books/n/gene/dfnx1/">DFNX1 nonsyndromic hearing loss and deafness</a> (DFN2) either disturb local stability of PRS-I or moderately affect interactions in the trimer interface.</p></div><div id="arts.Penetrance"><h3>Penetrance</h3><p>Penetrance in males is complete.</p></div><div id="arts.Prevalence"><h3>Prevalence</h3><p>Four kindreds with Arts syndrome have been identified worldwide [<a class="bk_pop" href="#arts.REF.de_brouwer.2007.507">de Brouwer et al 2007</a>, <a class="bk_pop" href="#arts.REF.synofzik.2014.24">Synofzik et al 2014</a>, <a class="bk_pop" href="#arts.REF.maruyama.2016.954">Maruyama et al 2016</a>].</p></div></div><div id="arts.Genetically_Related_Allelic_Disorde"><h2 id="_arts_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>The spectrum of <i>PRPS1</i>-related disorders includes four phenotypes &#x02013; <a href="/books/n/gene/prs/">PRS superactivity</a>, <a href="/books/n/gene/cmtx5/">CMTX5</a>, <a href="/books/n/gene/dfnx1/">DFNX1 nonsyndromic hearing loss and deafness</a> (DFN2), and Arts syndrome &#x02013; previously thought to be distinct entities (see <a class="figpopup" href="/books/NBK2591/table/arts.T.major_clinical_findings_in_prps1r/?report=objectonly" target="object" rid-figpopup="figartsTmajorclinicalfindingsinprps1r" rid-ob="figobartsTmajorclinicalfindingsinprps1r">Table 2</a>).</p><div id="arts.T.major_clinical_findings_in_prps1r" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Major Clinical Findings in <i>PRPS1</i>-Related Disorders by Phenotype</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK2591/table/arts.T.major_clinical_findings_in_prps1r/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__arts.T.major_clinical_findings_in_prps1r_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_1" rowspan="3" colspan="2" scope="colgroup" headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_1" style="text-align:left;vertical-align:middle;">Phenotype</th><th id="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2" colspan="6" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Findings</th><th id="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_3" rowspan="3" scope="col" colspan="1" headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_3" style="text-align:left;vertical-align:middle;">Distinguished<br />from Arts<br />Syndrome by:</th></tr><tr><th headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2" id="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1" colspan="5" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">In Hemizygous Males</th><th headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_2" id="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_2" rowspan="2" scope="col" colspan="1" style="text-align:left;vertical-align:middle;">In Heterozygous<br />Females</th></tr><tr><th headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1" id="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">GA</th><th headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1" id="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">PN</th><th headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1" id="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ID</th><th headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1" id="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SNHL</th><th headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1" id="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Other</th></tr></thead><tbody><tr><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/prs/">PRS super-activity</a></td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early-onset hyperuricemia, hyperuricosuria, hypotonia, ataxia</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In some: &#x02265;1 of these features</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Overproduction of purines</td></tr><tr><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Mild</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Late-onset hyperuricemia, hyperuricosuria; no obvious neurologic findings</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/cmtx5/">CMTX5</a></td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early-onset SNHL, optic neuropathy, progressive hypotonia, gait disturbances, loss of deep-tendon reflexes</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No symptoms</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No recurrent infections; see footnote 2</td></tr><tr><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/dfnx1/">DFNX1 nonsyndromic hearing loss and deafness</a> (DFN2)</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Late-onset SNHL; ataxia, hypotonia, hyperreflexia also reported&#x000a0;<sup>3</sup></td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No symptoms</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No recurrent infections; see footnote 4</td></tr><tr><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Arts syndrome</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_1 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_3_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Profound <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> SNHL, hypotonia, ataxia, optic atrophy, risk for infection</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_2 hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In some: <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> &#x00026;/or milder signs</td><td headers="hd_h_arts.T.major_clinical_findings_in_prps1r_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02013;</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">GA = gouty arthritis; ID = intellectual disability; PN = peripheral neuropathy; SNHL = sensorineural hearing loss</p></div></dd><dt>1. </dt><dd><div id="arts.TF.2.1"><p class="no_margin">No <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females have been described.</p></div></dd><dt>2. </dt><dd><div id="arts.TF.2.2"><p class="no_margin">CMTX is indistinguishable from Arts syndrome on serum uric acid testing.</p></div></dd><dt>3. </dt><dd><div id="arts.TF.2.3"><p class="no_margin"><a class="bk_pop" href="#arts.REF.arts.1993.535">Arts et al [1993]</a></p></div></dd><dt>4. </dt><dd><div id="arts.TF.2.4"><p class="no_margin">DFNX1 is indistinguishable from Arts syndrome on biochemical testing.</p></div></dd></dl></div></div></div></div><div id="arts.Differential_Diagnosis"><h2 id="_arts_Differential_Diagnosis_">Differential Diagnosis</h2><p>See <a href="#arts.Genetically_Related_Allelic_Disorde">Genetically Related Disorders</a>.</p></div><div id="arts.Management"><h2 id="_arts_Management_">Management</h2><div id="arts.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Arts syndrome, the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div>Neurologic evaluation for manifestations of hypotonia, ataxia, presence/absence of tendon reflexes</div></li><li class="half_rhythm"><div>Audiometry for evidence of hearing loss</div></li><li class="half_rhythm"><div>Eye examination for evidence of optic atrophy</div></li><li class="half_rhythm"><div>Assessment of intellectual abilities</div></li><li class="half_rhythm"><div>Analysis of the family <a class="def" href="/books/n/gene/glossary/def-item/pedigree/">pedigree</a> for other possible <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="arts.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Intellectual disability.</b> An individualized educational support program tailored to the individual&#x02019;s needs and based on assessment of cognitive abilities should be provided.</p><p><b>Ataxia.</b> See <a href="/books/n/gene/ataxias/#ataxias.Management">Hereditary Ataxias, Management</a>.</p><p><b>Sensorineural hearing loss.</b> See <a href="/books/n/gene/deafness-overview/#deafness-overview.Management">Hereditary Hearing Loss and Deafness Overview, Management</a>. Cochlear implantation in the two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> Australian males was associated with improved communication skills.</p><p><b>Optic atrophy</b>. No treatment is available.</p></div><div id="arts.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>Because of immune system compromise in males with Arts syndrome, the following are recommended:</p><ul><li class="half_rhythm"><div>An annual influenza immunization</div></li><li class="half_rhythm"><div>Routine immunizations against other common childhood infections (e.g., measles, mumps)</div></li></ul></div><div id="arts.Surveillance"><h3>Surveillance</h3><p>Cognitive impairment appears to be non-progressive, but repeat neuropsychologic assessments are recommended to help guide educational support programs.</p><p>Although the sensorineural deafness appears to be static (albeit very severe), regular audiologic assessment is recommended so that educational support can be optimized.</p><p>Visual impairment appears to be progressive; thus, regular evaluation by an ophthalmologist is recommended.</p></div><div id="arts.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#arts.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="arts.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Dietary <i>S</i>-adenosylmethionine (SAM) supplementation could theoretically alleviate some of the symptoms of Arts syndrome by providing an oral source of purine nucleotide precursor that is not phosphoribosyl pyrophosphate dependent. Furthermore, SAM is known to cross the blood-brain barrier. An adult with HPRT deficiency has been reported to benefit neurologically from SAM administration without untoward side effects [<a class="bk_pop" href="#arts.REF.glick.2006.687">Glick 2006</a>].</p><p>In an open-label clinical trial of SAM in two Australian brothers (ages 14 and 13 in 2010) with Arts syndrome [J Christodoulou et al, unpublished data; approved by the ethics and drug committees, Children's Hospital at Westmead, Sydney, Australia], oral SAM supplementation was set at 30 mg/kg/day. The brothers appear to have had significant benefit from this therapy based on decreased number of hospitalizations and stabilization of nocturnal BIPAP requirements; however, slight deterioration in their vision was noted. Eventually, they died at ages 19 and 18 years of respiratory failure associated with a severe lower respiratory tract infection.</p><p>Mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females from families with Arts syndrome may also benefit from SAM supplementation in their diet, although this remains to be tested.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="arts.Genetic_Counseling"><h2 id="_arts_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="arts.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Arts syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p></div><div id="arts.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have the disorder nor will he be <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for the <i>PRPS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; therefore, he does not require further evaluation/testing.</div></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a> (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>). Note: If a woman has more than one affected child and no other affected relatives and if the <i>PRPS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in her leukocyte DNA, she most likely has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li><li class="half_rhythm"><div>If a male is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case), the mother may be a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>) or the affected male may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>PRPS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, in which case the mother is not a carrier. The frequency of <i>de novo</i> pathogenic variants is not known.</div></li></ul><p><b>Parents of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>A female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> may have inherited the <i>PRPS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from either her mother or her father, or the pathogenic variant may be <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>. Of note, to date no male with Arts syndrome has been known to reproduce.</div></li><li class="half_rhythm"><div>Detailed evaluation of the parents and review of the extended family history may help distinguish probands with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from those with an inherited pathogenic variant. Molecular genetic testing of the mother (and possibly the father, or subsequently the father) can determine if the pathogenic variant was inherited.</div></li></ul><p><b>Sibs of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the genetic status of the mother:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <i>PRPS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%. Males who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the pathogenic variant will be heterozygotes (carriers) and may or may not be mildly affected.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <i>PRPS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of the mother, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the possibility of maternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Sibs of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the genetic status of the parents:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <i>PRPS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%. Males who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the pathogenic variant will be heterozygotes (carriers) and may or may not be mildly affected.</div></li><li class="half_rhythm"><div>If the father of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <i>PRPS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, he will transmit it to all his daughters and none of his sons.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <i>PRPS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Males with Arts syndrome do not reproduce.</p><p><b>Offspring of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Women with a <i>PRPS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have a 50% chance of transmitting the pathogenic variant to each child:</p><ul><li class="half_rhythm"><div>Males who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li><li class="half_rhythm"><div>Females who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will be heterozygotes (carriers) and may or may not be mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>Other family members.</b> If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> also has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her female family members may be at risk of being carriers (asymptomatic or symptomatic) and his or her male family members may be at risk of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> depending on their gender and genetic relationship to the proband.</p></div><div id="arts.Heterozygote_Carrier_Detection"><h3>Heterozygote (Carrier) Detection</h3><p>Molecular genetic testing of at-risk female relatives to determine their genetic status is most informative if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p><p>Note: (1) Females who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> (carriers) for this <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder may develop clinical findings related to the disorder, most notably late-onset (age &#x0003e;20 years) hearing impairment; ataxia, hypotonia, and hyperreflexia have been reported as well [<a class="bk_pop" href="#arts.REF.arts.1993.535">Arts et al 1993</a>]. (2) Identification of female heterozygotes requires either (a) prior identification of the <i>PRPS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family or, (b) if an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male is not available for testing, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> first by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, and if no pathogenic variant is identified, by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div><div id="arts.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or are heterozygotes (carriers), or who are at increased risk of being heterozygotes (carriers) or affected.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="arts.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>PRPS1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="arts.Resources"><h2 id="_arts_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Association on Intellectual and Developmental Disabilities (AAIDD)</b></div><div>501 3rd Street Northwest</div><div>Suite 200</div><div>Washington DC 20001</div><div><b>Phone:</b> 202-387-1968</div><div><b>Fax:</b> 202-387-2193</div><div><b>Email:</b> sis@aaidd.org</div><div><a href="http://www.aaidd.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aaidd.org</a></div></li><li class="half_rhythm"><div><b>American Society for Deaf Children (ASDC)</b></div><div>800 Florida Avenue Northeast</div><div>Suite 2047</div><div>Washington DC 20002-3695</div><div><b>Phone:</b> 800-942-2732 (Toll-free Parent Hotline); 866-895-4206 (toll free voice/TTY)</div><div><b>Fax:</b> 410-795-0965</div><div><b>Email:</b> info@deafchildren.org; asdc@deafchildren.org</div><div><a href="http://www.deafchildren.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.deafchildren.org</a></div></li><li class="half_rhythm"><div><b>National Ataxia Foundation</b></div><div>2600 Fernbrook Lane</div><div>Suite 119</div><div>Minneapolis MN 55447</div><div><b>Phone:</b> 763-553-0020</div><div><b>Email:</b> naf@ataxia.org</div><div><a href="http://www.ataxia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org</a></div></li><li class="half_rhythm"><div><b>National Center on Birth Defects and Developmental Disabilities</b></div><div>1600 Clifton Road</div><div>MS E-87</div><div>Atlanta GA 30333</div><div><b>Phone:</b> 800-232-4636 (toll-free); 888-232-6348 (TTY)</div><div><b>Email:</b> cdcinfo@cdc.gov</div><div><a href="http://www.cdc.gov/ncbddd/dd/ddmr.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intellectual Disability</a></div></li><li class="half_rhythm"><div><b>National Eye Institute</b></div><div>31 Center Drive</div><div>MSC 2510</div><div>Bethesda MD 20892-2510</div><div><b>Phone:</b> 301-496-5248</div><div><b>Email:</b> 2020@nei.nih.gov</div><div><a href="https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/low-vision" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Low Vision</a></div></li></ul></div><div id="arts.Molecular_Genetics"><h2 id="_arts_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="arts.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Arts Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK2591/table/arts.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__arts.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_arts.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_arts.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_arts.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_arts.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_arts.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_arts.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_arts.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5631" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PRPS1</i></a></td><td headers="hd_b_arts.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5631" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xq22<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_arts.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P60891" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ribose-phosphate pyrophosphokinase 1</a></td><td headers="hd_b_arts.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.molgen.ua.ac.be/CMTMutations/Mutations/Contexts.cfm?ID=43" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IPN Mutations, PRPS1</a><br /><a href="http://www.LOVD.nl/PRPS1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PRPS1 @ LOVD</a></td><td headers="hd_b_arts.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PRPS1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PRPS1</a></td><td headers="hd_b_arts.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PRPS1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PRPS1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="arts.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="arts.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Arts Syndrome (<a href="/omim/301835,311850" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK2591/table/arts.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__arts.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/301835" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">301835</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ARTS SYNDROME; ARTS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/311850" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">311850</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE I; PRPS1</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>PRPS1</i> consists of seven exons that code for ribose-phosphate pyrophosphokinase 1 (PRS-I), a protein of 318 amino acid residues. Only one isoform has been described for PRS-I. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK2591/#arts.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> To date, only four pathogenic variants have been identified (see <a class="figpopup" href="/books/NBK2591/table/arts.T.prps1_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figartsTprps1pathogenicvariantsdiscuss" rid-ob="figobartsTprps1pathogenicvariantsdiscuss">Table 3</a>), resulting in <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> changes at the protein level.</p><div id="arts.T.prps1_pathogenic_variants_discuss" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>PRPS1</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK2591/table/arts.T.prps1_pathogenic_variants_discuss/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__arts.T.prps1_pathogenic_variants_discuss_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_arts.T.prps1_pathogenic_variants_discuss_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_arts.T.prps1_pathogenic_variants_discuss_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_arts.T.prps1_pathogenic_variants_discuss_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_arts.T.prps1_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.398A&#x0003e;C</td><td headers="hd_h_arts.T.prps1_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln133Pro</td><td headers="hd_h_arts.T.prps1_pathogenic_variants_discuss_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?db=nuccore&#x00026;id=164663865" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_002764<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/entrez/viewer.fcgi?db=protein&#x00026;id=4506127" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_002755<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_arts.T.prps1_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.455T&#x0003e;C</td><td headers="hd_h_arts.T.prps1_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu152Pro</td></tr><tr><td headers="hd_h_arts.T.prps1_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.830A&#x02009;&#x0003e;&#x02009;C</td><td headers="hd_h_arts.T.prps1_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln277Pro</td></tr><tr><td headers="hd_h_arts.T.prps1_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.367C&#x0003e;G</td><td headers="hd_h_arts.T.prps1_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His123Asp</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> PRS-I catalyzes the synthesis of phosphoribosyl pyrophosphate (PRPP) from ATP and ribose-5-phosphate. PRPP is essential for the <i>de novo</i> synthesis of purine, pyrimidine, and pyridine nucleotides. For purine synthesis, PRPP is utilized as a substrate for PRPP amidotransferase, which is the first step in the <i>de novo</i> purine synthesis pathway, producing purine nucleotides such as ATP and GTP, and serves specifically as the rate-limiting reaction for purine nucleotide synthesis in vivo. PRPP is also essential for pyrimidine nucleotide synthesis, where it acts as cofactor for uridine monophosphate synthetase, which converts orotic acid into UMP, the precursor of other pyrimidine nucleotides including UTP, CTP, and TTP. Finally, PRPP is utilized for pyridine nucleotide synthesis by nicotinate phosphoribosyl transferase and nicotinamide phosphoribosyl transferase, which add a ribonucleotide moiety to nicotinic acid and nicotinamide respectively, which in turn are converted into the important cofactor NAD.</p><p>Apart from <i>de novo</i> synthesis of purine, pyrimidine, and pyridine nucleotides, PRPP is also essential for the salvage of purine bases by hypoxanthine guanine phosphoribosyl transferase and adenine phosphoribosyl transferase. This mechanism ensures efficient reutilization of purine bases and nucleosides, since <i>de novo</i> purine nucleotide synthesis using PRPP as the substrate requires a total of seven moles of ATP for generation of each mole of nucleotide, whereas salvage requires only one mole of ATP, for the synthesis of PRPP.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>In silico</i> molecular modeling predicted that both <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants would result in a loss of PRS-I activity, which was accordingly demonstrated by in vitro PRS enzyme assays in erythrocytes and fibroblasts from the Australian family and fibroblasts from the Dutch kindred. This was reflected by undetectable urine hypoxanthine and reduced plasma uric acid levels in the two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from the Australian family.</p></div><div id="arts.References"><h2 id="_arts_References_">References</h2><div id="arts.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="arts.REF.arts.1993.535">Arts WF, Loonen MC, Sengers RC, Slooff JL. X-linked ataxia, weakness, deafness, and loss of vision in early childhood with a fatal course. <span><span class="ref-journal">Ann Neurol. </span>1993;<span class="ref-vol">33</span>:535–9.</span> [<a href="/pubmed/8498830" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8498830</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arts.REF.de_brouwer.2007.507">de Brouwer AP, Williams KL, Duley JA, van Kuilenburg AB, Nabuurs SB, Egmont-Petersen M, Lugtenberg D, Zoetekouw L, Banning MJ, Roeffen M, Hamel BC, Weaving L, Ouvrier RA, Donald JA, Wevers RA, Christodoulou J, van Bokhoven H. Arts syndrome is caused by loss-of-function mutations in PRPS1. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">81</span>:507–18.</span> [<a href="/pmc/articles/PMC1950830/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1950830</span></a>] [<a href="/pubmed/17701896" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17701896</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arts.REF.glick.2006.687">Glick N. Dramatic reduction in self-injury in Lesch-Nyhan disease following S-adenosylmethionine administration. <span><span class="ref-journal">J Inherit Metab Dis. </span>2006;<span class="ref-vol">29</span>:687.</span> [<a href="/pubmed/16906475" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16906475</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arts.REF.maruyama.2016.954">Maruyama K, Ogaya S, Kurahashi N, Umemura A, Yamada K, Hashiguchi A, Takashima H, Torres RJ, Aso K. Arts syndrome with a novel missense mutation in the PRPS1 gene: A case report. <span><span class="ref-journal">Brain Dev. </span>2016;<span class="ref-vol">38</span>:954–8.</span> [<a href="/pubmed/27256512" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27256512</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arts.REF.synofzik.2014.24">Synofzik M, M&#x000fc;ller vom Hagen J, Haack TB, Wilhelm C, Lindig T, Beck-W&#x000f6;dl S, Nabuurs SB, van Kuilenburg AB, de Brouwer AP, Sch&#x000f6;ls L. X-linked Charcot-Marie-Tooth disease, Arts syndrome, and prelingual non-syndromic deafness form a disease continuum: evidence from a family with a novel PRPS1 mutation. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2014;<span class="ref-vol">9</span>:24.</span> [<a href="/pmc/articles/PMC3931488/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3931488</span></a>] [<a href="/pubmed/24528855" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24528855</span></a>]</div></li></ul></div></div><div id="arts.Chapter_Notes"><h2 id="_arts_Chapter_Notes_">Chapter Notes</h2><div id="arts.Acknowledgments"><h3>Acknowledgments</h3><p>The authors are grateful to the families of the Dutch and Australian patients for providing samples used for biochemical and molecular analyses over a number of years.</p></div><div id="arts.Author_History"><h3>Author History</h3><p>Arjan PM de Brouwer, PhD (2008-present)<br />John Chrstodoulou, MBBS, PhD (2008-present)<br />John A Duley, PhD; University of Queensland (2008-2018)</p></div><div id="arts.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>22 March 2018 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>29 March 2011 (cd) Revision: edits to Differential Diagnosis</div></li><li class="half_rhythm"><div>4 January 2011 (cd) Revision: changes to Therapies Under Investigation</div></li><li class="half_rhythm"><div>18 November 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>21 October 2008 (me) Review posted live</div></li><li class="half_rhythm"><div>3 June 2008 (apmb) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK2591</span><span class="label">PMID: <a href="/pubmed/20301738" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301738</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/arterial-t/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mld/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK2591&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK2591/?report=reader">PubReader</a></li><li><a href="/books/NBK2591/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK2591" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK2591" style="display:none" title="Cite this Page"><div class="bk_tt">de Brouwer APM, Christodoulou J. Arts Syndrome. 2008 Oct 21 [Updated 2018 Mar 22]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK2591/pdf/Bookshelf_NBK2591.pdf">PDF version of this page</a> (410K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#arts.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#arts.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#arts.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#arts.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#arts.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#arts.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#arts.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#arts.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#arts.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#arts.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#arts.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5631[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PRPS1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK2591+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1478634" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1478634" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1478634" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1478634" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301734" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphoribosylpyrophosphate Synthetase Superactivity</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphoribosylpyrophosphate Synthetase Superactivity<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">de Brouwer APM, Duley JA, Christodoulou J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301731" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy X Type 5</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy X Type 5<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kim JW, Kim HJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24278995" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moog U, Uyanik G, Kutsche K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21834172" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> DFNX1 Nonsyndromic Hearing Loss and Deafness</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> DFNX1 Nonsyndromic Hearing Loss and Deafness<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Liu XZ, Yuan H, Mittal R, Yan D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301398" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Simpson-Golabi-Behmel Syndrome Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Simpson-Golabi-Behmel Syndrome Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sajorda BJ, Gonzalez-Gandolfi CX, Hathaway ER, Kalish JM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301738" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301738" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc8f0975f66d18aa50e5a6">Arts Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Arts Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:06:17-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE884D11DFC848F1000000000502023F&amp;ncbi_session=CE884D11DFC8F091_1282SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK2591%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK2591&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK2591/&amp;ncbi_pagename=Arts Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE884D11DFC8F091_1282SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>